J Rehabil Res Dev 2002 Mar-Apr;39(2):175-85
Pozzilli C, Romano S, Cannoni S.
Department of Neurological Science, University of Rome, La Sapienza, Italy.
Multiple sclerosis (MS) is a chronic disease affecting the central nervous system, usually leading to early disablement in young adults.
At least 350,000 persons in Europe have the disease.
Wide variations exist both between and within European countries in the incidence and prevalence of the disease as well as in the general standard of care for MS patients.
The needs, well-being, and social participation of people with MS are systematically influenced by their physical and cultural environment and the nature of the community services.
Moreover, the rate of introduction of the new disease-modifying therapy also widely differs from country to country.
This article helps clinical researchers to understand better the differences in epidemiology and in the current treatment of MS in Europe.